Advertisement

Expert Opinion: Omega-3 Fatty Acids and Bleeding—Cause for Concern?

  • William S. Harris
    Correspondence
    Address for reprints: William S. Harris, PhD, Department of Medicine, Sanford School of Medicine of the University of South Dakota, 1400 West 22nd Street, Sioux Falls, South Dakota 57105.
    Affiliations
    Sanford School of Medicine of the University of South Dakota, Sioux Falls, South Dakota, USA.
    Search for articles by this author
Published:November 30, 2006DOI:https://doi.org/10.1016/j.amjcard.2006.11.021
      Omega-3 fatty acid ethyl esters have well-known triglyceride-lowering properties and were shown >30 years ago to inhibit platelet function. With the recent US Food and Drug Administration (FDA) approval of these agents for treating severe triglyceride elevations, concerns about excess bleeding naturally arise. However, an objective assessment of the evidence for clinically significant bleeding reveals that such concerns are unfounded. As such, the benefits of triglyceride lowering with omega-3 fatty acids more than outweigh any theoretical risks for increased bleeding.
      To read this article in full you will need to make a payment

      References

        • Bays H.E.
        Safety considerations with omega-3 fatty acid therapy.
        Am J Cardiol. 2007; 99: 35C-43C
        • Eritsland J.
        • Arnesen H.
        • Gronseth K.
        • Fjeld N.B.
        • Abdelnoor M.
        Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency.
        Am J Cardiol. 1996; 77: 31-36
        • DeCaterina R.
        • Giannessi D.
        • Mazzone A.
        • Bernini W.
        • Lazzerini G.
        • Maffei S.
        • Cerri M.
        • Salvatore L.
        • Weksler B.
        Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery.
        Circulation. 1990; 82: 428-438
        • Nye E.R.
        • Ablett M.B.
        • Robertson M.C.
        • Ilsley C.D.
        • Sutherland W.H.
        Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty.
        Aust N Z J Med. 1990; 20: 549-552
        • Bellamy C.M.
        • Schofield P.M.
        • Faragher E.B.
        • Ramsdale D.R.
        Can supplementation of diet with omega-3 polyunsaturated fatty acids reduce coronary angioplasty restenosis rate?.
        Eur Heart J. 1992; 13: 1626-1631
        • Leaf A.
        • Jorgensen M.B.
        • Jacobs A.K.
        • Cote G.
        • Schoenfeld D.A.
        • Scheer J.
        • Weiner B.H.
        • Slack J.D.
        • Kellett M.A.
        • Raizner A.E.
        • et al.
        Do fish oils prevent restenosis after coronary angioplasty?.
        Circulation. 1994; 90: 2248-2257
        • Dehmer G.J.
        • Popma J.J.
        • van den Berg E.K.
        • Eichhorn E.J.
        • Prewitt J.B.
        • Campbell W.B.
        • Jennings L.
        • Willerson J.T.
        • Schmitz J.M.
        Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids.
        N Engl J Med. 1988; 319: 733-740
        • Franzen D.
        • Schannwell M.
        • Oette K.
        • Hopp H.W.
        A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following PTCA.
        Cathet Cardiovasc Diagn. 1993; 28: 301-310
        • Milner M.R.
        • Gallino R.A.
        • Leffingwell A.
        • Pichard A.D.
        • Brooks-Robinson S.
        • Rosenberg J.
        • Little T.
        • Lindsay Jr, J.
        Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty.
        Am J Cardiol. 1989; 64: 294-299
        • Cairns J.A.
        • Gill J.
        • Morton B.
        • Roberts R.
        • Gent M.
        • Hirsh J.
        • Holder D.
        • Finnie K.
        • Marquis J.F.
        • Naqvi S.
        • Cohen E.
        • EMPAR Study
        Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty.
        Circulation. 1996; 94: 1553-1560
        • Grigg L.E.
        • Kay T.W.
        • Valentine P.A.
        • Larkins R.
        • Flower D.J.
        • Manolas E.G.
        • O’Dea K.
        • Sinclair A.J.
        • Hopper J.L.
        • Hunt D.
        Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty.
        J Am Coll Cardiol. 1989; 13: 665-672
        • Kaul U.
        • Sanghvi S.
        • Bahl V.K.
        • Dev V.
        • Wasir H.S.
        Fish oil supplements for prevention of restenosis after coronary angioplasty.
        Int J Cardiol. 1992; 35: 87-93
        • Bairati I.
        • Roy L.
        • Meyer F.
        Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty.
        Circulation. 1992; 85: 950-956
        • Reis G.J.
        • Boucher T.M.
        • Sipperly M.E.
        • Silverman D.I.
        • McCabe C.H.
        • Baim D.S.
        • Sacks F.M.
        • Grossman W.
        • Pasternak R.C.
        Randomised trial of fish oil for prevention of restenosis after coronary angioplasty.
        Lancet. 1989; 2: 177-181
        • Johansen O.
        • Brekke M.
        • Seljeflot I.
        • Abdelnoor M.
        • Arnesen H.
        N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART [Coronary Angioplasty Restenosis Trial] study.
        J Am Coll Cardiol. 1999; 33: 1619-1626
        • Maresta A.
        • Balduccelli M.
        • Varani E.
        • Marzilli M.
        • Galli C.
        • Heiman F.
        • Lavezzari M.
        • Stragliotto E.
        • De Caterina R.
        Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for Prevention of Restenosis (ITalian Study ESPRIT).
        Am Heart J. 2002; 143: E5
        • Thies F.
        • Garry J.M.
        • Yaqoob P.
        • Rerkasem K.
        • Williams J.
        • Shearman C.P.
        • Gallagher P.J.
        • Calder P.C.
        • Grimble R.F.
        Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial.
        Lancet. 2003; 361: 477-485
        • Rapp J.H.
        • Connor W.E.
        • Lin D.S.
        • Porter J.M.
        Dietary eicosapentaenoic acid and docosahexaenoic acid from fish oil: their incorporation into advanced human atherosclerotic plaques.
        Arterioscler Thromb. 1991; 11: 903-911
        • von Schacky C.
        • Angerer P.
        • Kothny W.
        • Theisen K.
        • Mudra H.
        The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled trial.
        Ann Intern Med. 1999; 130: 554-562
        • Sacks F.M.
        • Stone P.H.
        • Gibson C.M.
        • Silverman D.I.
        • Rosner B.
        • Pasternak R.C.
        Controlled trial of fish oil for regression of human coronary atherosclerosis.
        J Am Coll Cardiol. 1995; 25: 1492-1498
        • Knapp H.R.
        Dietary fatty acids in human thrombosis and hemostasis.
        Am J Clin Nutr. 1997; 65: 1687S-1698S
        • Olsen S.F.
        • Sorensen J.D.
        • Secher N.J.
        • Hedegaard M.
        • Henriksen T.B.
        • Hansen H.S.
        • Grant A.
        Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration.
        Lancet. 1992; 339: 1003-1007
        • Donnelly S.M.
        • Ali M.A.
        • Churchill D.N.
        Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients.
        J Am Soc Nephrol. 1992; 2: 1634-1639
        • Lempert K.D.
        • Rogers II, J.S.
        • Albrink M.J.
        Effects of dietary fish oil on serum lipids and blood coagulation in peritoneal dialysis patients.
        Am J Kidney Dis. 1988; 11: 170-175
        • Clarke J.T.
        • Cullen-Dean G.
        • Regelink E.
        • Chan L.
        • Rose V.
        Increased incidence of epistaxis in adolescents with familial hypercholesterolemia treated with fish oil.
        J Pediatr. 1990; 116: 139-141
        • Goren A.
        • Stankiewicz H.
        • Goldstein R.
        • Drukker A.
        Fish oil treatment of hyperlipidemia in children and adolescents receiving renal replacement therapy.
        Pediatrics. 1991; 88: 265-268